Clarient's InsightDx Mammostrat test could help clinicians to decide which breast cancer patients should receive aggressive treatment, a study has suggested. The diagnostic is designed to predict the risk of recurrence in patients with oestrogen receptor-positive breast cancer, the ...
Please Login to read the full article.
